Iceman - I don't know how old you are, but there are many companies that do this and come back strongly. The biggest sign of faith is the management buying heavily into shares. If they were headed to bankruptcy, why would they want to get paid in shares? Come on now. Your logic is flawed.
I most recently invested in ADXS where the management did an offering for $3 a share when it was at $5 over a year ago. Adding insult to injury, management then passed an amendment increasing their stock options. At the time it seemed crazy, but veteran investors know that when management has so much interest in holding their shares, then it must mean something. ADXS is now at $15+ and going up today.
My point being, this happens all the time. The leap of faith is in the fact that management is buying heavily into the offering. Even if this stock is fully diluted today, the price can go to $1 easy.
Sentiment: Strong Buy
Well, the stock offering price is $0.40 with warrants attached, so it is standing at about par if you consider the warrants to be worth $0.10. The other bio dilution, CYCC is trading much more significantly under the offering at the moment.
This will require some patience, as the management puts together the pieces in this company.
Speaking of buyout, I don't think that's happening anytime soon. Ideally, a partnership to come into North America. If a buyout, it would be for around $1 a share max - fully diluted.
iceman - many of us have been here much longer than you, and know what's going on. You showed up here last week and think you own this board. This whole 'Paid Pumper' thing is getting old.
Once this stock breaks $0.40 you'll really be gone.
If you be so brave, tell us when you started shorting? $0.28? Is that why you're panicking and have desperate posts?
Sentiment: Strong Buy
Hmm morningstar or their 10k? Tough decision.
Ice: What's your position? Boy do I hope you are short...atleast it sounds like it, with these desperate posts.
1) The fact that they have completed the dilution for next 6 months.
2) The fact that the insiders want shares - and a lot of it.
3) The fact that they have a plan going forward, and have Sol Barer on BOD.
4) The fact that they are starting to execute since the voluntary recall, starting with NYSE regulatory compliance.
5) Way oversold stock.
Nah - I just sold at $1.88 when the big crash came through in 2013 I think. I literally bought at the top, when there were buyout talks, and rode it to them bottom -_-. At that point, I just wanted to get out of AMRN. I am happy that they are having somewhat of a rebirth now, especially for the older investors. However, doesn't look pretty today.
I've only invested in a few biotechs. ACAD at $1.50 a share in 2011, AMRN at $13 a share in 2013, ADXS at $3.00 a share in 2014. I did good with ACAD and ADXS, but AMRN tore me down 70% I believe. I learned a lesson to not hold through binary events!
The other stock I am currently watching is MEIP (catalyst March 31st).
To be honest, I'm never sure about short term, as in this week. Short term is driven by day traders and their agenda. However, long term is driven by company execution and management.
I think the stock is positioned to hit $0.40 in the near future and continue it's climb up to it's 50 day moving average.
I bought this stock primarily because of the fundamentals. I believe this is a $1 stock at the very least by December 31st. I will hold through the next few earnings to see the progress the company has made. There are many partnerships, and revenue growth measures to be announced, which can take this up quickly.
Agreed. The traders should be coming in droves anytime now. Just need a solid close for the day - the week will shape out to speak for itself after.
Buyout candidate is most likely for Boston Scientific. I doubt management would sell the company for anything less than $300-500M. A company like SPNC may or may not be able to pull that off. BSX, with its 22B$ MC definitely has the room for this.
They also have deep connections to Boston Scientific, with much of the Senior Management Team from BSX.
I believe there is a big seller who has been unloading shares. That is always the issue with companies like Aegis - they never have an intent of carrying through the offering, because of small pockets.
This being said, once this is finished the stock should realize it's true value. This reminds me of ADXS when I bought in at the offering for $3. The stock lingered for a couple weeks in that range as Aegis cleared its shares, but then took off. Today it's at $14.
Stay long and strong!
Sentiment: Strong Buy
That analyst is an idiot pa1702. He issued buy ratings at $3, and then again at $2 when they recalled their product.
Now when they get back on track, he downgrades? LOL what a joker